Logout
 ACCP Evidence-Based
 Guidelines
    Definitions of
   ACCP Evidence-Based
   Guidelines, Consensus
   Statements, and Other
   Reviews and Projects
   Current ACCP
   Guidelines
   External Resources
   Guideline Development
   Guideline Proposal
   Application
   Guideline Request
   For Endorsement
   Instructions to Authors
   Products
   ACCP Guidelines
   in the News
   Evidence Based
   Medicine
 CME Certificates
 Education Calendar
 Online Education
 Center of Excellence for
 Learning and Teaching
 Consensus Statements
 
 

Beta Blockers Best After Cardiac Surgery

MONDAY, August 8 (HealthDay News) -- Beta blockers are the top choice for control and prevention of irregular heartbeat, according to the first evidence-based clinical guidelines for postoperative atrial fibrillation after cardiac surgery.

The guidelines, released August 8 by the American College of Chest Physicians, appear in the August issue of CHEST. Atrial fibrillation (AF), or irregular heartbeat, is one of the most frequent complications of cardiac surgery.

"Over one third of patients suffer from AF after cardiac surgery, which is associated with a higher risk of postoperative morbidity, increased hospital stay, and increased hospital cost," guidelines co-chairman Peter McKeown, of the Veterans Affairs Medical Center in Asheville, N.C., said in a prepared statement.

"Although previous guidelines have focused on the management of chronic AF, our guidelines are the first to address AF associated with cardiac surgery," McKeown said.

The new guidelines offer recommendations on cardiac pacing, anticoagulation therapy, pharmaceutical prophylaxis, intraoperative interventions, and the use of drugs to control ventricular rate and rhythm.